Journal of Controlled Release

Article	Citations
Pickering emulsion-guided monomeric delivery of monophosphoryl lipid A for enhanced vaccination	475
Hybrid prodrug nanoassembly for hypoxia-triggered immunogenic chemotherapy and immune modulation	370
The pharmacokinetic profile of mitomycin C released from an injectable supramolecular hydrogel in a rodent model	369
Collagenase-modified polydopamine nanoparticles for safe and effective vitreolysis	337
Lanthanide nanocrystals-based direct triple-state energy converters for mitophagy and ferroptosis-induced antitumor immunoreaction	328
Designing and modeling nanomedicines towards image-guided drug delivery in hematological malignancies	318
Coordinated modulation of glucose metabolism and immunity via metal-drug nanovesicles for hepatocellular carcinoma therapy	316
Outside Front Cover	302
Hypoxia-responsive oncolytic conjugate triggers type-II immunogenic cell death for enhanced photodynamic immunotherapy	289
Alendronate-functionalized polymeric micelles target icaritin to bone for mitigating osteoporosis in a rat model	282
Oxygen-boosted fluorinated prodrug hybrid nanoassemblies for bidirectional amplification of breast cancer ferroptosis	255
Optimized bacterial delivery approaches for precision immunotherapy in breast cancer models	252
Nanoparticle-based methionine and AICAR delivery elicits a robust antitumor immune response	241
Dasatinib and erianin co-loaded ion-responsive in-situ hydrogel for effective treatment of corneal neovascularization	239
Inside Back Cover	225
Corrigendum to “Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch” [Journal of Controlled Release 372 (2024) 304–317]	222
Outside Back Cover	217
Dual-stimulus phototherapeutic nanogel for triggering pyroptosis to promote cancer immunotherapy	202
Digging the intercellular crosstalk via extracellular vesicles: May exosomes be the drug delivery solution for target glioblastoma?	190
Single-cell RNA transcriptome landscape of murine liver following systemic administration of mesoporous silica nanoparticles	188
Outside Back Cover	188
In vivo self-assembled small RNA targets H19 lncRNA for the treatment of colorectal cancer	188
A self-assembled graphene oxide adjuvant induces both enhanced humoral and cellular immune responses in influenza vaccine	187
Impact of interferon-γ on the target cell tropism of nanoparticles	185
Cavitation-assisted sonothrombolysis by asymmetrical nanostars for accelerated thrombolysis	183

Combinatorial physical methods for cellular therapy: Towards the future of cellular analysis?	183
MSC-derived extracellular vesicles as nanotherapeutics for promoting aged liver regeneration	177
Unleashing the potential of cell biomimetic nanoparticles: Strategies and challenges in their design and fabrication for therapeutic applications	158
An efficient (nano) silica - In glucan particles protein encapsulation approach for improved thermal stability	156
Tumor permeable self-delivery nanodrug targeting mitochondria for enhanced chemotherapy	155
The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair	155
An engineered dual function peptide to repair fractured bones	154
Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases	147
Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy	146
Prediction of drug capturing by lipid emulsions in vivo for the treatment of a drug overdose	143
Nano-trapping CXCL13 reduces regulatory B cells in tumor microenvironment and inhibits tumor growth	139
Adaptable peptide-based therapeutics modulating tumor microenvironment for combinatorial radio-immunotherapy	138
Integrative approaches to enhance adeno-associated viral gene delivery	138
Surface programmed bacteria as photo-controlled NO generator for tumor immunological and gas therapy	138
Nanoparticle-mediated thermal Cancer therapies: Strategies to improve clinical translatability	135
Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H2S scavenging for colitis treatment	133
Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis	132
Functional nanoplatform for modulating cellular forces to enhance antitumor immunity via mechanotransduction	132
Extracellular vesicles for renal therapeutics: State of the art and future perspective	131
Healing with precision: A multi-functional hydrogel-bioactive glass dressing boosts infected wound recovery and enhances neurogenesis in the wound bed	128
Identification of functional biomarkers for personalized nanomedicine in advanced breast cancer in vitro models	127
Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment	123
Transdermal carbon monoxide delivery	119
Conditioned media-integrated microneedles for hair regeneration through perifollicular angiogenesis	118
Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice	115
ZIF-8-modified hydrogel sequentially delivers angiogenic and osteogenic growth factors to accelerate vascularized bone regeneration	112
Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation	112
Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease	110
In vivo delivery of antioxidant enzymes with multi-functionalized lipid nanoparticles for sepsis therapy	109
Multifunctional delivery strategies and nanoplatforms of SN-38 in cancer therapeutics	107
Autophagy-activating aluminum hydroxide nanovaccine for enhanced antigen presentation and anti-tumor immunity	107
Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors	107
Enhanced browning of adipose tissue by mirabegron-microspheres	106
Enhancing gene transfection of poly(β-amino ester)s through modulation of amphiphilicity and chain sequence	106
Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3	104
Surface-engineered mesenchymal stem cell for refractory asthma therapy: Reversing airway remodeling	104
Outside Front Cover: Yisheng Peng et al	104
Dynamic versus static testing and in vivo mechanical performance of poly(glycolide-trimethylene carbonate-ε-caprolactone) delayed release implants	103
Outside Back Cover	101
Orthogonal upconversion nanocarriers for combined photodynamic therapy and precisely triggered gene silencing in combating keloids	101
Combination of multivalent DR5 receptor clustering agonists and histone deacetylase inhibitors for treatment of colon cancer	99
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin	97
Biomimetic reactive oxygen/nitrogen nanoscavengers inhibit “ferroptosis storm” and modulate immune targeting for acute kidney injury	97
Multifunctional nanoparticles potentiate in-situ tumor vaccines via reversing insufficient Photothermal therapy by disrupting tumor vasculature	97
Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention	96
Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy	96
Biomaterial scaffolds for therapeutic immune cell engineering and delivery	96
The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules	96
Customization of protein corona to reprogram cancer nanomedicines: Mechanistic insights and therapeutic implications	96
Injectable nanocomposite hydrogel with cascade drug release for treatment of uveal melanoma	95

Melittin-incorporated nanomedicines for enhanced cancer immunotherapy	94
Mechanism exploration of intestinal mucus penetration of nano-Se: regulated by polysaccharides with different functional groups and molecular weights	93
Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug	93
Metal-phenolic network-based polymeric nanocarriers facilitating antibody cytoplasmic delivery and anti-tumor effects to orthotopic breast tumors	93
Thermoresponsive polymeric dexamethasone prodrug for arthritis pain	93
Full-cycle study on developing a novel structured micromixer and evaluating the nanoparticle products as mRNA delivery carriers	93
A next-generation STING agonist MSA-2: From mechanism to application	92
Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies	92
Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients	92
Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy	91
Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer	91
A smart cauliflower-like carrier for astaxanthin delivery to relieve colon inflammation	91
In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma	90
A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes	89
Ferroptosis boosted oral cancer photodynamic therapy by carrier-free Sorafenib-Ce6 self-assembly nanoparticles	89
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs	88
Mechanisms of uptake and transport of particulate formulations in the small intestine	87
Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment	86
Oral mucosal vaccination using integrated fiber microneedles	86
The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome	86
Self-assembly hydrogels of therapeutic agents for local drug delivery	86
Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis	85
Complement opsonization of nanoparticles: Differences between humans and preclinical species	85
Hybrid nanopotentiators with dual cascade amplification for glioma combined interventional therapy	85
Inside front cover: Yufan Qian et al	84
Outside Back Cover: Yujie Wang et al	84
Photothermal-controlled NO-releasing Nanogels reverse epithelial-mesenchymal transition and restore immune surveillance against cancer metastasis	84
Editorial Board	84
Corrigendum to “Size-specific clonidine-loaded liposomes: Advancing melanoma microenvironment suppression with safety and precision” [Journal of Controlled Release, Volume 379, 10 March 2025, Pages 12	84
Restoring tumor antigenicity activates the “bystander” T cell immune cycle	84
Nanoparticle-mediated synergistic disruption of tumor innervation and redox homeostasis for potent antineoplastic therapy	84
Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating endoplasmic reticulum function in colon cancer	83
Modulation of GABAergic neurons in acute epilepsy using sonogenetics	83
Substrate-free dissolving microneedles with barbed shape to increase adhesion and drug-delivery efficiency to skin	81
Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T1 magnetic resonance imaging	81
Enhancing protective immunity against SARS-CoV-2 with a self-amplifying RNA lipid nanoparticle vaccine	81
Hyperglycemia-responsive nitric oxide-releasing biohybrid cryogels with cascade enzyme catalysis for enhanced healing of infected diabetic wounds	80
Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke	78
Linoleic acid co-administration promotes oral delivery of exenatide-loaded butyrate-decorated nanocapsules	78
Dual-corn-derived nanofiber membrane for subconjunctival injury: Sequential release of dual-natural products for programmed anti-inflammation and anti-fibrosis	78
Molecular engineering of extracellular vesicles for drug delivery: Strategies, challenges, and perspectives	77
Chemo-photothermal nanoplatform with diselenide as the key for ferroptosis in colorectal cancer	77
Programmable hierarchical hydrogel dressing for sequential release of growth factor and DNase to accelerate diabetic wound healing	77
Pre-mixing of omega-3 fatty acid-containing liposomes enhances the drug release rate and therapeutic efficacy of anticancer drugs loaded in liposomes	77
Outside Front Cover	77
Multimodal nanoparticles co-delivering bevacizumab and dichloroacetate for dual targeting of neoangiogenesis and hyperglycolysis in glioblastoma treatment	76
Unleashing the power of nucleic acid therapeutics through efficient cytosolic delivery	76
Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates	76
Inside Front Cover	76
Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection	75
Inorganic nanomaterials for drug delivery and therapeutic applications: Promise, pitfalls, and publication standards in Journal of Controlled Release	75
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity	75
Design of lipid-based formulations for oral delivery of a BASP1 peptide targeting MYC-dependent gastrointestinal cancer cells	75
In situ formed reactive oxygen species-responsive dipyridamole prodrug hydrogel: Spatiotemporal drug delivery for chemoimmunotherapy	75
Injectable thermosensitive hydrogel for local and controlled delivery of siRNA-STAT3 polyplexes to treat advanced-stage ovarian cancer	74
A trinity STING-activating nanoparticle harnesses cancer cell STING machinery for enhanced immunotherapy	74
Clinically relevant dosing of miR-145 micelles curbs atherosclerosis in vivo	73
Controlled release of manganese and magnesium ions by microsphere-encapsulated hydrogel enhances cancer immunotherapy	73
Size matters: Altering antigen specific immune tolerance by tuning size of particles	73
Corrigendum to “Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy” [Journal of Controlled Release 353 (2023) 447–461]	72
Low-boiling-point perfluorocarbon nanodroplets for adaptable ultrasound-induced blood-brain barrier opening	72
Strengthening scientific credibility in the face of misinformation and disinformation: Viable solutions	72
Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis	72
Solvent electrospinning amorphous solid dispersions with high itraconazole, celecoxib, mebendazole and fenofibrate drug loading and release potential	72
Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer	71
Inside Front Cover	71
Thermal/ultrasound-triggered release of liposomes loaded with Ganoderma applanatum polysaccharide from microbubbles for enhanced tumour ablation	71
Nano-engineered immune cells as “guided missiles” for cancer therapy	70
Outside Front Cover	70
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges	70
Outside Front Cover	69
Nano-chemical priming strategy to enhance TGF-β resistance and anti-tumor activity of natural killer cells	69
Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions	69
Programmed T cells infiltration into lung metastases with harnessing dendritic cells in cancer immunotherapies by catalytic antigen-capture sponges	69
Inside Back Cover	69
Inside Back Cover	69
Protein-based delivery systems for RNA delivery	68
Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes	68
A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy	68
Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy	67

A polymer‑calcium phosphate nanocapsule for RNAi-induced oxidative stress and cascaded chemotherapy	67
Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections	67
Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route	67
Engineered bacterial extracellular vesicles for central nervous system diseases	67
Advocation and advancements of EPR effect theory in drug delivery science: A commentary	67
Zeolite imidazolate framework-8 in bone regeneration: A systematic review	66
Tet1 peptide and zinc (II)-adenine multifunctional module functionalized polycations as efficient siRNA carriers for Parkinson's disease	66
Orthogonal and complementary measurements of properties of drug products containing nanomaterials	66
Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy	66
Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice	65
Promotion or inhibition of extracellular vesicle release: Emerging therapeutic opportunities	65
Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension	65
Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics	65
Nanoadjuvants Actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels	65
Transitioning from a lab-scale PLGA microparticle formulation to pilot-scale manufacturing	64
Acetyl-lysine human serum albumin nanoparticles activate CD44 receptors, with preferential uptake by cancer stem cells, leading to tumor eradication	64
A preparation method for mRNA-LNPs with improved properties	64
Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor	63
Stimulator of interferon genes-targeted positron emission tomography tracks early microbiota-induced tumor immune remodeling and guides immunotherapy	63
Combating cisplatin-resistant lung cancer using a coiled-coil lipopeptides modified membrane fused drug delivery system	63
Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer	63
Strategies of tea polyphenol-mediated delivery systems based on Mannich reaction for precision nutrition	63
An “IgG-hitchhiking” approach for rapid tumor accumulation and clearance of photosensitizers	63
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine	63
Nebulized inhalation of LPAE-HDAC10 inhibits acetylation-mediated ROS/NF-κB pathway for silicosis treatment	63
Multifunctional mPDA@Mel-AB/BG hydrogels: Integrating ROS scavenging, inflammation suppression, and cartilage repair for osteoarthritis therapy	63
Reversible opening of the blood-labyrinth barrier by low-pressure pulsed ultrasound and microbubbles for the treatment of inner ear diseases	63
Nanodrugs based on co-delivery strategies to combat cisplatin resistance	63
An engineered α1β1 integrin-mediated FcγRI signaling component to control enhanced CAR macrophage activation and phagocytosis	63
Editorial Board	63
Hierarchically structured hydrogel exhibiting spatiotemporal release profiles: Enabling digital remote diagnosis and personalized therapeutics	63
LIPUS-responsive meropenem-loaded nanobubbles enable biofilm disruption and bone repair in orthopedic implant-associated infections	63
Microneedle patch-involved local therapy synergized with immune checkpoint inhibitor for pre- and post-operative cancer treatment	63
COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice	63
Efficient pulmonary fibrosis therapy via regulating macrophage polarization using respirable cryptotanshinone-loaded liposomal microparticles	62
Cross-linked selenolipoic acid nanoplatform modulates intracellular and extracellular reactive oxygen species for cancer immunotherapy	62
Structural stability and RNase resistance of mRNA Polyplex micelles for systemic delivery	62
Engineered vesicular cancer vaccines for immunosuppressive microenvironment reversion and in situ vaccine generation	61
In memoriam: Professor Rimona Margalit (1941–2024)	61
Manganese-induced Photothermal-Ferroptosis for Synergistic Tumor Therapy	61
Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs	61
Corrigendum to “Overcoming P-glycoprotein-mediated multidrug resistance in cancer cells through micelle-forming PHPMA-b-PPO diblock copolymers for doxorubicin delivery” [Journal of Controlled Release	61
Fine-tuning of liposome integrity for differentiated transcytosis and enhanced antitumor efficacy	60
Corrigendum to “Ultrasound-responsive polymersomes capable of endosomal escape for efficient cancer therapy” [Journal of Controlled Release 322 (2020) 81–94]	60
Construction of novel magnetic systems for cancer immunotherapy via cancer-immunity cycle circuits	60
A glycopolymersome strategy for ‘drug-free’ treatment of diabetic nephropathy	60
Shear force and cholesterol affinity responsive drug delivery system for treating inflammation and abnormal lipid metabolism in atherosclerosis	60
In situ vaccine “seeds” for enhancing cancer immunotherapy by exploiting apoptosis-associated morphological changes	60
A bifunctional nanocomplex with remineralizing and antibacterial activities to interrupt dental caries	60
An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy	59
Editorial Board	59
Gastrointestinal-inert prebiotic micro-composites improve the growth and community diversity of mucosal-associated bacteria.	59
Multifunctional nanocomposite hydrogel with dual-factor controlled release for stem cell recruitment, immunomodulation and bone remodeling	59
Inside Front Cover	59
Cardiosplenic axis-targeted immunomodulatory liposome for myocardial ischemia-reperfusion injury treatment	59
Outside Front Cover	59
Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: From near-infrared-I to near-infrared-II	58
Smart delivery systems for microbial biofilm therapy: Dissecting design, drug release and toxicological features	58
Next generation therapeutics for retinal neurodegenerative diseases	58
LncRNA-edited biomimetic nanovaccines combined with anti-TIM-3 for augmented immune checkpoint blockade immunotherapy	58
Biomimetic-gasdermin-protein-expressing nanoplatform mediates tumor-specific pyroptosis for cancer immunotherapy	58
Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer	58
A novel peptide hydrogel of metal ion clusters for accelerating bone defect regeneration	57
Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy	57
Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats	57
Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment	57
A bionic “Trojan horse”-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy	56
Levodopa-loaded nanoparticles for the treatment of Parkinson's disease	56
Platelet-mimicking supramolecular nanomedicine with precisely integrated prodrugs for cascade amplification of synergistic chemotherapy	56
Acid-base transformative HADLA micelles alleviate colitis by restoring adaptive immunity and gut microbiome	55
Tiny tots for a big-league in wound repair: Tools for tissue regeneration by nanotechniques of today	55
Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarction	55
Influence of focused ultrasound on locoregional drug delivery to the brain: Potential implications for brain tumor therapy	55
Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer	54
Modulating albumin-mediated transport of peptide-drug conjugates for antigen-specific Treg induction	54
Engineered macrophages acting as a trigger to induce inflammation only in tumor tissues	54
Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery	54
Determining topical product bioequivalence with stimulated Raman scattering microscopy	54
Strategic aspects for the commercialization of nanomedicines	54
DNA nanotechnology-facilitated ligand manipulation for targeted therapeutics and diagnostics	53
High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics	53
Reinforcing vascular normalization therapy with a bi-directional nano-system to achieve therapeutic-friendly tumor microenvironment	53
Stimuli-responsive and biomimetic delivery systems for sepsis and related complications	53
Hyaluronidase-powered microneedles for significantly enhanced transdermal delivery efficiency	53
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product	52
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment	52
Curcumin-release antibacterial dressings with antioxidation and anti-inflammatory function for diabetic wound healing and glucose monitoring	52
All layers matter: Innovative three-dimensional epithelium-stroma-endothelium intestinal model for reliable permeability outcomes	52
Protein-based nanocages for vaccine development	52
Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression	52
Micelle-to-Gel: Thermosensitive intra-articular hydrogels for osteoarthritis management	52
Glioma-derived exosomes hijack the blood–brain barrier to facilitate nanocapsule delivery via LCN2	52
Prospects for hypoxia-based drug delivery platforms for the elimination of advanced metastatic tumors: From 3D modeling to clinical concepts	52
Intra-articular delivery of full-length antibodies through the use of an in situ forming depot	52
Current state of the art in peptide-based gene delivery	51